Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

LRP overexpression in monocytic lineage.

Béatrice Ly Sunnaram1, Virginie Gandemer, Martine Sebillot

  • 1Laboratoire d'Hématologie, Hôpital Sud, Université de Rennes, 16 Boulevard de Bulgarie, Rennes 35203, France.

Leukemia Research
|June 13, 2003
PubMed
Summary

Lung resistance protein (LRP) is not a prognostic indicator for chemotherapy failure in acute myeloid leukemia (AML). However, LRP expression is statistically linked to monoblastic leukemias, suggesting its diagnostic utility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French Experience.

Transplantation and cellular therapy·2026
Same author

External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database.

Multiple sclerosis and related disorders·2026
Same author

Upfront alemtuzumab-based MUD HSCT in childhood aplastic anemia: excellent survival and GRFS, but immune challenges persist.

Bone marrow transplantation·2026
Same author

Increased Susceptibility to Long-Term Complications in Leukemia Survivors Who Received Hematopoietic Stem Cell Transplantation During Adolescence.

Transplantation and cellular therapy·2026
Same author

Hyperammonemia in children treated with asparaginase for acute lymphoblastic leukaemia.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same author

High-speed trains versus air transport vectors for mass transfers of critically ill patients: The TRANSCOV cohort study.

PloS one·2026

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Chemotherapy failure in leukemia is multifactorial.
  • Lung resistance protein (LRP) overexpression is implicated in drug resistance, but its role remains debated.
  • Previous studies explored LRP and P170 (multidrug resistance) in leukemias.

Purpose of the Study:

  • To investigate the expression of LRP in various subtypes of acute myeloid leukemia (AML).
  • To determine the correlation between LRP expression and clinical outcome in AML patients.
  • To assess the potential of LRP as a diagnostic marker for monocytic leukemias.

Main Methods:

  • Immunocytochemical (ICC) method used to study LRP and P170 expression.
  • Expression of LRP scored from 1 to 5 in blast cells and monocytes separately.

Related Experiment Videos

  • Analysis of 47 AML cases across different French-American-British (FAB) subtypes.

    • Main Results:

    • LRP expression was not correlated with clinical outcome in AML.
    • A statistically significant relationship was found between LRP expression and monoblastic leukemias (FAB M5 subtype).
    • Strongest LRP overexpression observed in monoblastic leukemias, chronic myelomonocytic leukemia, reactive monocytosis, and a dendritic cell line.

    Conclusions:

    • Lung resistance protein (LRP) serves as a marker for monocytic lineage rather than a prognostic index for multidrug resistance (MDR).
    • ICC detection of LRP may aid in diagnosing monoblastic and monocytic leukemias.